133 related articles for article (PubMed ID: 17456491)
1. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly.
Lehmann GB; Asskali F; Boll M; Burmeister MA; Marx G; Hilgers R; Förster H
Br J Anaesth; 2007 May; 98(5):635-44. PubMed ID: 17456491
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6 : 1 and hydroxyethyl starch 130/0.4/9 : 1.
Lehmann G; Marx G; Förster H
Drugs R D; 2007; 8(4):229-40. PubMed ID: 17596109
[TBL] [Abstract][Full Text] [Related]
3. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
4. Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics?
Madjdpour C; Dettori N; Frascarolo P; Burki M; Boll M; Fisch A; Bombeli T; Spahn DR
Br J Anaesth; 2005 May; 94(5):569-76. PubMed ID: 15734780
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers.
Waitzinger J; Bepperling F; Pabst G; Opitz J
Drugs R D; 2003; 4(3):149-57. PubMed ID: 12757400
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
Jungheinrich C; Scharpf R; Wargenau M; Bepperling F; Baron JF
Anesth Analg; 2002 Sep; 95(3):544-51, table of contents. PubMed ID: 12198032
[TBL] [Abstract][Full Text] [Related]
7. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation.
Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
Transfusion; 1996 May; 36(5):450-5. PubMed ID: 8693511
[TBL] [Abstract][Full Text] [Related]
8. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs.
Thyes C; Madjdpour C; Frascarolo P; Buclin T; Bürki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2006 Dec; 105(6):1228-37. PubMed ID: 17122586
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery.
Behne M; Thomas H; Bremerich DH; Lischke V; Asskali F; Förster H
Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615
[TBL] [Abstract][Full Text] [Related]
10. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.
Langeron O; Doelberg M; Ang ET; Bonnet F; Capdevila X; Coriat P
Anesth Analg; 2001 Apr; 92(4):855-62. PubMed ID: 11273914
[TBL] [Abstract][Full Text] [Related]
11. Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation.
Jamnicki M; Bombeli T; Seifert B; Zollinger A; Camenzind V; Pasch T; Spahn DR
Anesthesiology; 2000 Nov; 93(5):1231-7. PubMed ID: 11046211
[TBL] [Abstract][Full Text] [Related]
12. Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats.
Leuschner J; Opitz J; Winkler A; Scharpf R; Bepperling F
Drugs R D; 2003; 4(6):331-8. PubMed ID: 14584961
[TBL] [Abstract][Full Text] [Related]
13. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
Suttner S; Boldt J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
[TBL] [Abstract][Full Text] [Related]
14. Modern rapidly degradable hydroxyethyl starches: current concepts.
Boldt J
Anesth Analg; 2009 May; 108(5):1574-82. PubMed ID: 19372338
[TBL] [Abstract][Full Text] [Related]
15. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.
Bellmann R; Feistritzer C; Wiedermann CJ
Clin Pharmacokinet; 2012 Apr; 51(4):225-36. PubMed ID: 22420578
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and safety of 6 % hydroxyethyl starch 130/0.4 in healthy male volunteers of Japanese ethnicity after single infusion of 500 ml solution.
Yamakage M; Bepperling F; Wargenau M; Miyao H
J Anesth; 2012 Dec; 26(6):851-7. PubMed ID: 22729229
[TBL] [Abstract][Full Text] [Related]
17. Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.
Schramm S; Thyes C; Frascarolo P; Buclin T; Burki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
Anesthesiology; 2007 Sep; 107(3):442-51. PubMed ID: 17721247
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: influence of molecular weight and degree of substitution.
Eisenbach C; Schönfeld AH; Vogt N; Wente MN; Encke J; Stremmel W; Martin E; Pfenninger E; Weigand MA
Intensive Care Med; 2007 Sep; 33(9):1637-44. PubMed ID: 17554522
[TBL] [Abstract][Full Text] [Related]
19. Influence of intravascular molecular weight of hydroxyethyl starch on platelets.
Treib J; Haass A; Pindur G; Treib W; Wenzel E; Schimrigk K
Eur J Haematol; 1996 Mar; 56(3):168-72. PubMed ID: 8598237
[TBL] [Abstract][Full Text] [Related]
20. An international view of hydroxyethyl starches.
Treib J; Baron JF; Grauer MT; Strauss RG
Intensive Care Med; 1999 Mar; 25(3):258-68. PubMed ID: 10229159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
